Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 6.85 ($0.09) and traded as low as GBX 6.70 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares trading hands.
Venn Life Sciences Price Performance
The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48. The firm has a market capitalization of £4.89 million and a P/E ratio of -2.14. The business has a 50 day moving average price of GBX 6.85 and a 200 day moving average price of GBX 6.85.
Venn Life Sciences Company Profile
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Read More
- Five stocks we like better than Venn Life Sciences
- Consumer Staples Stocks, Explained
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Why Are Stock Sectors Important to Successful Investing?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.